How did pharma's lobbyists score on reform?

Take a look behind the healthcare reform scenes in Washington, DC, and you'll see what pharma lobbyists have done to protect--and help--the industry in return for their $110 million in fees. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.